Dermatomyositis

被引:137
作者
Callen, Jeffrey P. [1 ]
Wortmann, Robert L.
机构
[1] Univ Louisville, Sch Med, Div Dermatol, Louisville, KY 40202 USA
[2] Univ Oklahoma, Coll Med, Dept Med, Tulsa, OK 74135 USA
关键词
D O I
10.1016/j.clindermatol.2006.07.001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Dermatomyositis is one of the idiopathic inflammatory myopathies. It is characterized clinically by progressive symmetrical proximal muscle weakness and a characteristic rash. There are patients with rash who have little or no muscle disease. Although the process primarily attacks the skin and the muscles, it is a systemic disease with frequent manifestations in the gastrointestinal tract and pulmonary system. Dermatomyositis has been linked to internal malignancy in somewhere between 15% and 25%. Therapy for the muscle disease includes systemic corticosteroids with or without an immunosuppressive agent. Therapy of the skin disease begins with photoprotection and topical corticosteroids, but also includes the use of antimalarial agents and immunomodulatory therapies. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:363 / 373
页数:11
相关论文
共 103 条
[61]   Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis [J].
Oryoji, K ;
Himeji, D ;
Nagafuji, K ;
Horiuchi, T ;
Tsukamoto, H ;
Gondo, H ;
Harada, M .
CLINICAL RHEUMATOLOGY, 2005, 24 (06) :637-640
[62]  
Pachman Lauren M., 1995, Current Opinion in Rheumatology, V7, P437, DOI 10.1097/00002281-199509000-00013
[63]   Duration of illness is an important variable for untreated children with juvenile dermatomyositis [J].
Pachman, LM ;
Abbott, K ;
Sinacore, JM ;
Amoruso, L ;
Dyer, A ;
Lipton, R ;
Ilowite, N ;
Hom, C ;
Cawkwell, G ;
White, A ;
Rivas-Chacon, R ;
Kimura, Y ;
Ray, L ;
Ramsey-Goldman, R .
JOURNAL OF PEDIATRICS, 2006, 148 (02) :247-253
[64]  
Pachman LM, 2000, ARTHRITIS RHEUM, V43, P2368, DOI 10.1002/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO
[65]  
2-8
[66]   History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry [J].
Pachman, LM ;
Lipton, R ;
Ramsey-Goldman, R ;
Shamiyeh, E ;
Abbott, K ;
Mendez, EP ;
Dyer, A ;
McCurdy, D ;
Vogler, L ;
Reed, A ;
Cawkwell, G ;
Zemel, L ;
Sandborg, C ;
Rivas-Chacon, R ;
Hom, C ;
Ilowite, N ;
Gedalia, A ;
Gitlin, J ;
Borzy, M .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (02) :166-172
[67]  
Pautas E, 2000, CLIN EXP RHEUMATOL, V18, P241
[68]   Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus [J].
Pelle, MT ;
Callen, JP .
ARCHIVES OF DERMATOLOGY, 2002, 138 (09) :1231-1233
[69]  
PENG JC, 1995, ARCH OTOLARYNGOL, V121, P1298
[70]   MYOSITIS - IMMUNOLOGICAL CONTRIBUTIONS TO UNDERSTANDING CAUSE, PATHOGENESIS, AND THERAPY [J].
PLOTZ, PH ;
RIDER, LG ;
TARGOFF, IN ;
RABEN, N ;
OHANLON, TP ;
MILLER, FW .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (09) :715-724